APA (7th ed.) Citation

Chancellor, J., Hunsche, E., de Cruz, E., & Sarasin, F. (2001). Economic Evaluation of Celecoxib, a New Cyclo-Oxygenase 2 Specific Inhibitor, in Switzerland. PharmacoEconomics, 19(8), 59. https://doi.org/10.2165/00019053-200119001-00005

Chicago Style (17th ed.) Citation

Chancellor, J.V.M, E. Hunsche, E. de Cruz, and F.P Sarasin. "Economic Evaluation of Celecoxib, a New Cyclo-Oxygenase 2 Specific Inhibitor, in Switzerland." PharmacoEconomics 19, no. 8 (2001): 59. https://doi.org/10.2165/00019053-200119001-00005.

MLA (9th ed.) Citation

Chancellor, J.V.M, et al. "Economic Evaluation of Celecoxib, a New Cyclo-Oxygenase 2 Specific Inhibitor, in Switzerland." PharmacoEconomics, vol. 19, no. 8, 2001, p. 59, https://doi.org/10.2165/00019053-200119001-00005.